Guaiamar dripping pill

Abstract

The present invention discloses a kind of cough-relieving and phlegm-eliminating medicine composition, and is especially orally taken medicine composition dripping pill with guaiamar as active component. The guaiamar dripping pill has great medicine carrying amount, fast medicine releasing, fast acting, high bioavailability, less toxic side effect, convenient taking and low cost. The guaiamar dripping pill is prepared with guaiamar as active component, and through adding medicinal carrier as matrix, heating to obtain melt and / or emulsion and / or suspension of guaiamar and matrix, and dropping into condensating agent in dripping pill machine to form through shrinking.

Description

technical field [0001] The invention relates to a pharmaceutical composition for relieving cough and removing phlegm, in particular to an oral preparation of the pharmaceutical composition with guaiacol as an active ingredient. Background technique [0002] According to statistics, respiratory diseases account for about 1 / 4 of internal medicine patients. In my country's population statistics, respiratory diseases are the second cause of death. The main symptoms of respiratory diseases are cough, sputum and asthma. In recent years, there are gradually more and more drugs available in clinical practice, and guaiacol is one of them. [0003] Guaifenesin (GF) is an expectorant, which can reduce the viscosity of sputum, reduce the foul smell of sputum, and relax smooth muscle. It is mainly used for cold, cough, bronchitis and other diseases in clinical practice. The drug is soluble in water and ethanol, and is rapidly absorbed in the gastrointestinal tract, with a peak time of a...

AI Technical Summary

Problems solved by technology

Due to the characteristics of their preparation technology, tablets and capsules usually have problems such as long dissolution time, low dissolution rate, poor absorption, low bioavailability, and prone to hepatic and intestinal first-pass effects, which affect drug efficacy. full play

[0007] In addition, there is still the inflexibility of making compound preparations according to disease and individual conditions, and choosing a better combination of drugs for treatment

At the same time, conventional tablets and capsules use a large amount of auxiliary materials, and the relative cost is also high, which increases a certain economic burden for patients.